Multiple Sclerosis New Zealand - Latest News [Page 2]
MSNZ welcomes consultation period for Tysabri and Gilenya
Friday, 8 August 2014, 3:05 pm | Multiple Sclerosis New Zealand
MSNZ welcomes beginning of consultation period for Tysabri and Gilenya as proposed new first-line treatments for relapsing remitting forms of Multiple Sclerosis. More >>